Search research articles
Contact Us
Filters
Showing results (81-90 of 100) with videos related to
Page
of 10
Sort By:
The Lancet. Oncology
|
September 16, 2011
HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data
Angelo Di Leo, Christine Desmedt, John M S Bartlett, et al.
Journal of Medical Internet Research
|
March 7, 2025
Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study
Samer El Kababji, Nicholas Mitsakakis, Elizabeth Jonker, et al.
JAMA
|
October 22, 2019
Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: The FIBRES Randomized Clinical Trial
Jeannie Callum, Michael E Farkouh, Damon C Scales, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 12, 2026
The Desert Immune Phenotype in Endometrial Carcinoma: A Distinct Subgroup With Poor Prognosis and Targetable Mutations
Merve Kaya, Lawrence H Lin, Jan Oosting, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2010
Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors
James N Ingle, Daniel J Schaid, Paul E Goss, et al.
Cancer
|
September 10, 2020
Higher serum PD-L1 level predicts increased overall survival with lapatinib versus trastuzumab in the CCTG MA.31 phase 3 trial
Prashanth Moku, Lois Shepherd, Suhail M Ali, et al.
Gynecologic Oncology
|
January 11, 2026
Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/ SHAPE trial
Se Ik Kim, Jae-Weon Kim, Janice S Kwon, et al.
Journal of the National Cancer Institute
|
February 2, 2021
The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32
Isabel Pimentel, Bingshu E Chen, Ana Elisa Lohmann, et al.
Blood
|
January 9, 2013
A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial
A Keith Stewart, Suzanne Trudel, Nizar J Bahlis, et al.
The Oncologist
|
April 25, 2015
Defining breast cancer intrinsic subtypes by quantitative receptor expression
Maggie C U Cheang, Miguel Martin, Torsten O Nielsen, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 100) with videos related to
Sort By:
Page
of 10
The Lancet. Oncology
|
September 16, 2011
HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data
Angelo Di Leo, Christine Desmedt, John M S Bartlett, et al.
Journal of Medical Internet Research
|
March 7, 2025
Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study
Samer El Kababji, Nicholas Mitsakakis, Elizabeth Jonker, et al.
JAMA
|
October 22, 2019
Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: The FIBRES Randomized Clinical Trial
Jeannie Callum, Michael E Farkouh, Damon C Scales, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 12, 2026
The Desert Immune Phenotype in Endometrial Carcinoma: A Distinct Subgroup With Poor Prognosis and Targetable Mutations
Merve Kaya, Lawrence H Lin, Jan Oosting, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2010
Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors
James N Ingle, Daniel J Schaid, Paul E Goss, et al.
Cancer
|
September 10, 2020
Higher serum PD-L1 level predicts increased overall survival with lapatinib versus trastuzumab in the CCTG MA.31 phase 3 trial
Prashanth Moku, Lois Shepherd, Suhail M Ali, et al.
Gynecologic Oncology
|
January 11, 2026
Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/ SHAPE trial
Se Ik Kim, Jae-Weon Kim, Janice S Kwon, et al.
Journal of the National Cancer Institute
|
February 2, 2021
The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32
Isabel Pimentel, Bingshu E Chen, Ana Elisa Lohmann, et al.
Blood
|
January 9, 2013
A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial
A Keith Stewart, Suzanne Trudel, Nizar J Bahlis, et al.
The Oncologist
|
April 25, 2015
Defining breast cancer intrinsic subtypes by quantitative receptor expression
Maggie C U Cheang, Miguel Martin, Torsten O Nielsen, et al.
Page
of 10